Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 27;5(3):440-446.
doi: 10.1002/jha2.923. eCollection 2024 Jun.

Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia

Jyoti Shaw  1 , Abhilipsa Patra  2 , Anjumana Khatun  1 , Rudra Ray  1 , Amit Ghosh  2 , Sonali Mahapatra  3 , Ashutosh Panigrahi  3 , Maitreyee Bhattacharyya  1
Affiliations

Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia

Jyoti Shaw et al. EJHaem. .

Abstract

The phenotype of β-thalassemia varies widely. The primary determinant is the type of beta-globin gene mutation; however, there are secondary and tertiary modifiers also as associated alpha mutations, polymorphisms, as well as coinheritance of mutations affecting other related systems. Co-inheritance of alpha thalassemia mutations is known to ameliorate the severity of HbE-β thalassemia. However, the role of alpha globin gene alterations (deletions and triplication) is not well illustrated in homozygous β-thalassemia. Here we evaluated the role of alpha globin gene alterations in 122 β-thalassemia patients having IVS1-5 (G > C) homozygous mutation. β-thalassemia mutations were detected by ARMS PCR and alpha mutations by GAP-PCR. Gene expression by qRT-PCR. Out of 122 cases, 15 patients had alpha 3.7 triplications (ααα3.7anti), 24 had alpha 3.7 kb deletion (-α3.7) mutation and three patients had 4.2 kb deletion (-α4.2). Patients were divided into two groups, requiring less than 8 units (NTDT) and more than 8 units (TDT) of blood transfusion per year (≥8U BT/year). The percentage of alpha deletion was significantly (p = 0.0042) high in NTDT (42.1%) as compared with TDT (13.2%). Conversely, the proportion of alpha triplication is high in the TDT as compared with NTDT. Even mean serum ferritin level was found to be significantly high in patients having alpha triplication as compared with those having alpha deletions (p = 0.0184) and normal alpha gene (p = 0.0003). α/β globin ratio was highest in TDT patients with alpha triplication and lowest in NTDT patients with alpha-del. The results show that concurrent inheritance of alpha gene alterations influences the phenotypic severity of homozygous β-thalassemia.

Keywords: alpha deletion; alpha‐triplication; beta‐thalassemia; co‐inheritance; homozygous.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Distribution of alpha globin gene mutation in the β‐thal homo patients. The pie chart shows the distribution of alpha globin gene deletion/triplication among the homozygous β‐thal patients.
FIGURE 2
FIGURE 2
Comparison based on the baseline Hb level. (A) Bar‐graph shows the percentage of patients having baseline Hb ≥7 g/dL or Hb < 7 g/dL. (B) A composite bar diagram of the percentage distribution of alpha globin gene mutation among the two levels of baseline Hb.
FIGURE 3
FIGURE 3
Comparison between NTDT (BT < 8/year) and TDT (≥8/year) β‐thal patients. (A) Bar‐graph shows the percentage of NTDT and TDT patients. (B) The composite bar diagram of the percentage distribution of alpha globin gene mutation among the two groups.
FIGURE 4
FIGURE 4
Relative quantification of alpha globin gene. (A) Bar‐graph shows the genefold expression (2−∆∆CT) between NTDT and TDT. (B) The composite bar diagram of genefold expression among the different genotypes of the alpha globin gene.
See this image and copyright information in PMC

References

    1. Balgir RS. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci. 2000:1536–1547.
    1. Colah R, Italia K, &Gorakshakar A Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84. 10.1016/j.phoj.2017.10.002 - DOI
    1. Farashi S, Harteveld CL Molecular basis of α‐thalassemia. Blood Cells Mol Dis. 2018;70:43–53. 10.1016/j.bcmd.2017.09.004 - DOI - PubMed
    1. Thaker P, Mahajan N, Mukherjee MB, Colah RB Molecular heterogeneity of Hb H disease in India. Thalassemia Reports. 2022;12(3):73–84. 10.3390/thalassrep12030012 - DOI
    1. Nadkarni A, Phanasgaonkar S, Colah R, Mohanty D, & Ghosh K Prevalence and molecular characterization of α‐thalassemia syndromes among Indians. Genet Test. 2008;12(2):177–180. 10.1089/gte.2007.0080 - DOI - PubMed